dual CTLA-4 checkpoint inhibitor/4-1BB costimulator (Alligator Bioscience)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namedual CTLA-4 checkpoint inhibitor/4-1BB costimulator (Alligator Bioscience)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 agonistsCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors

TargetsTumor necrosis factor receptor superfamily member 9Cytotoxic T-Lymphocyte-Associated Antigen 4

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySweden

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAlligator Bioscience Ab

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAlligator Bioscience Ab

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A